Roble, Belko & Company, Inc Gsk PLC Call Options Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GSK
# of Institutions
20Shares Held
176KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.47 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.14 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$678,7580.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL18.6KShares$631,9950.0% of portfolio
-
Loveless Wealth Management LLC15KShares$509,7390.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $69.1B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...